FDA Approves Olaparib/Bevacizumab Maintenance FDA Approves Olaparib/Bevacizumab Maintenance
The FDA has announced a new approved indication for olaparib in adults with advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
More News: Avastin | Cancer | Cancer & Oncology | Epithelial Cancer | Fallopian Tube Cancer | Hematology | Ovarian Cancer | Ovaries | Peritoneal Cancer